Jpmorgan Chase & CO Pacific Biosciences Of California, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 468,880 shares of PACB stock, worth $754,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
468,880
Previous 468,880 -0.0%
Holding current value
$754,896
Previous $600,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$1.17 - $1.69 $61,371 - $88,647
-52,454 Reduced 10.06%
468,880 $600,000
Q1 2025

May 12, 2025
BUY
$1.14 - $2.1 $7,785 - $14,340
6,829 Added 1.33%
521,334 $615,000
Q4 2024

Feb 12, 2025
SELL
$1.55 - $2.65 $77,503 - $132,505
-50,002 Reduced 8.86%
514,505 $941,000
Q3 2024

Dec 26, 2024
BUY
$1.2 - $2.17 $55,148 - $99,726
45,957 Added 8.86%
564,507 $959,000
Q3 2024

Nov 08, 2024
BUY
$1.2 - $2.17 $55,148 - $99,726
45,957 Added 8.86%
564,507 $959,000
Q2 2024

Dec 26, 2024
SELL
$1.36 - $3.65 $62,501 - $167,743
-45,957 Reduced 8.14%
518,550 $710,000
Q2 2024

Aug 12, 2024
SELL
$1.36 - $3.65 $466,266 - $1.25 Million
-342,843 Reduced 39.8%
518,550 $710,000
Q1 2024

Dec 26, 2024
BUY
$3.52 - $9.59 $1.05 Million - $2.85 Million
296,886 Added 52.59%
861,393 $3.23 Million
Q1 2024

May 10, 2024
SELL
$3.52 - $9.59 $1.49 Million - $4.05 Million
-421,879 Reduced 32.88%
861,393 $3.23 Million
Q4 2023

Dec 26, 2024
BUY
$5.97 - $10.36 $4.29 Million - $7.45 Million
718,765 Added 127.33%
1,283,272 $12.6 Million
Q4 2023

Feb 12, 2024
SELL
$5.97 - $10.36 $1.31 Million - $2.27 Million
-219,163 Reduced 14.59%
1,283,272 $12.6 Million
Q3 2023

Nov 14, 2023
BUY
$8.23 - $13.93 $1.43 Million - $2.42 Million
173,562 Added 13.06%
1,502,435 $12.5 Million
Q2 2023

Aug 11, 2023
BUY
$9.97 - $14.05 $1.2 Million - $1.69 Million
119,997 Added 9.93%
1,328,873 $17.7 Million
Q1 2023

May 18, 2023
BUY
$7.94 - $12.02 $2.4 Million - $3.63 Million
301,812 Added 33.27%
1,208,876 $14 Million
Q1 2023

May 11, 2023
BUY
$7.94 - $12.02 $719,705 - $1.09 Million
90,643 Added 11.1%
907,064 $10.5 Million
Q4 2022

Feb 13, 2023
BUY
$5.67 - $11.2 $558,477 - $1.1 Million
98,497 Added 13.72%
816,421 $6.68 Million
Q3 2022

Nov 14, 2022
SELL
$3.93 - $8.57 $237,765 - $518,485
-60,500 Reduced 7.77%
717,924 $4.17 Million
Q2 2022

Aug 11, 2022
SELL
$4.02 - $10.43 $954,327 - $2.48 Million
-237,395 Reduced 23.37%
778,424 $3.44 Million
Q1 2022

May 11, 2022
BUY
$8.43 - $20.9 $6.31 Million - $15.6 Million
748,630 Added 280.19%
1,015,819 $9.24 Million
Q4 2021

Feb 10, 2022
BUY
$19.26 - $30.08 $366,941 - $573,084
19,052 Added 7.68%
267,189 $5.47 Million
Q3 2021

Nov 12, 2021
BUY
$24.86 - $35.02 $6.17 Million - $8.69 Million
248,137 New
248,137 $6.34 Million

Others Institutions Holding PACB

# of Institutions
246
Shares Held
190M
Call Options Held
1.27M
Put Options Held
601K
View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB Quotes by TradingView
  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $362M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email